and B5-fixed tissues. Using this panel of mAb, we show that M2A antigen is an O-linked sialoglycoprotein containing a simple mucin-type carbohydrate epitope. Furthermore, since mAb M2A does not react with specimens routinely fixed in formalin during conventional preservation (Giwercman et al, 1991) , we used mAb D2-40 to stain sections of 69 archival blocks of TGCT, fixed in formalin and embedded in paraffin, in order to extend our previous results on the distribution of M2A antigen. We confirm uniform membrane staining for M2A antigen in SE and CIS in the vicinity of all TGCT. We also report focal staining for M2A antigen in EC, IT and MT and YS, not previously detected in frozen sections using mAb M2A (Bailey et al, 1991) .
MATERIALS AND METHODS

Human tumour cell lines
The following human tumour cell lines were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA): ovary -Caov-3 (ATCC HTB-75) and SK-OV-3 (ATCC HTB-77); bone -U-2 OS (ATCC HTB-96); bone marrow -KG-1a (ATCC CCL-246.1); cervix -HeLa (ATCC CCL-2). The other cell lines were generously provided by the following investigators: ovary -HEY and HOC-7 (R Buick, University of Toronto), and NIH:OVCAR-3 (RF Ozols, Fox Chase Cancer Center); bladder -RT4, MGH-U3 and T-24 (Y Fradet, Laval University); breast -MCF7 (R Buick), MDA-MB-468 (R Reilly, University of Toronto); prostate -DU 145, PC-3 and LNCaP (T Brown, University of Toronto); colon -Caco-2 (B Schimmer, University of Toronto); pharynx -KB-3-1 (M Gottesman, National Institutes of Health); melanoma -CaCL 74-36 and CaCL 78-1 (S-K Liao, McMaster University), and WM 164 (J. Hainfeld, Brookhaven National Laboratory). The cell lines were grown in monolayer culture, except for KG-1a which was grown in suspension culture, in minimal essential medium (MEM)-α (University of Toronto Media Center, Toronto, ON, Canada) supplemented with 10% heat-inactivated fetal bovine serum and L-glutamine (Gibco-BRL, Gaithersburg, MD, USA) at 37°C, in a humidified 5% carbon dioxide incubator.
Monoclonal antibodies
mAb M2A was produced by immunizing BALB/c mice with the human ovarian epithelial carcinoma cell line HEY, as previously described (Bailey et al, 1986) , and D1-26 and D2-40 by immunization with DG tissue resected from a female patient. Hybridoma colonies were initially screened by enzyme-linked immunosorbent assay (ELISA) for production of mouse IgG. Hybridomas which produced IgG were screened directly for immunoperoxidase staining of sections of formalin-fixed, paraffin-embedded human SE and tonsil tissue. Hybridomas which produced mAb reacting with SE, but not tonsil, were cloned twice by limiting dilution. mAb were purified from ascitic fluid as previously described , according to protocols approved by the University of Toronto Animal Care Committee.
Determination of binding affinities of mAb to HEY cells
mAb D1-26 and D2-40 were labelled with 125 I using N-bromosuccinimide, as described previously (Buckman et al, 1992) . mAb M2A was labelled with 125 I using the Bolton Hunter reagent,
N-succinimidyl-3-(4-hydroxyphenyl)-propionate
(Amersham, Oakville, ON, Canada) . The binding affinities of the mAb to HEY cells were determined by two methods: first, direct binding using a Scatchard plot, and second, displacement of binding with increasing amounts of unlabelled mAb, as previously described .
Western blotting
The cells were harvested by trypsinization and recovered by centrifugation. The cell pellet was suspended at a concentration of 1-2 × 10 7 cells per ml in lysis buffer, 150 mM sodium chloride (NaCl), 2 mM EDTA, 10 mM Tris-HCl, pH 8.0, containing 0.5% Nonidet P-40 and 2 mM phenylmethylsulphonyl fluoride (PMSF; Sigma, St Louis, MO, USA). After 20-30 min at 4°C, nuclei and cellular debris were removed by centrifugation at 100 000 g for 30 min. The clarified supernatants were stored at -70°C until use. Cell lysates of the following human cell lines, testicular teratocarcinoma 577, Tera-1 and Tera-2, embryonal carcinoma 833 and 1618, ovarian teratocarcinoma PA-1, and glioblastoma T98G (King et al, 1997) , were kindly provided by Dr David Hogg (University of Toronto). Aliquots containing 10 µg of protein were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) in 10% slab gels under reducing conditions. Western blotting was performed as previously described (Bailey et al, 1986) except that the secondary antibody was the peroxidase-conjugated F(ab´) 2 fragment of goat anti-mouse IgG antibody (Jackson Immuno Research, West Grove, PA, USA) used at a 1:10 000 dilution. The blots were developed using enhanced chemiluminescence (ECL, Amersham) and exposed to X-ray film, or alternatively, by addition of the peroxidase substrate, 0.05% diaminobenzidine and 0.03% hydrogen peroxide (H 2 O 2 ) in phosphate-buffered saline (PBS).
Lectin affinity chromatography
HEY cell lysates were subjected to lectin affinity chromatography on columns of concanavalin A, Ricinus communis agglutinin and wheat germ agglutinin (WGA), eluted with 10% α-methyl D-mannose, 10% D-galactose and 5% N-acetyl-D-glucosamine, respectively, as described previously (Sutherland et al, 1988) . The presence of antigen reacting with mAb M2A in the bound and the unbound fractions was assessed by Western blotting.
Antigen purification
The protocol for antigen purification was adapted from our previously published procedures (Sutherland et al, 1988) , as follows. A pellet of 2 × 10 9 HEY cells was suspended at 4°C in 25 ml of lysis buffer and the cell lysate was prepared and stored at -70°C, as described above. Following thawing, the cell lysate was applied to a WGA-Sepharose 4B column, and the bound glycoprotein fraction was eluted with 5% N-acetyl-D-glucosamine in lysis buffer. The eluate was adjusted to 0.5 M NaCl, and subjected to affinity chromatography on an immunoaffinity column, prepared by cross-linking 10 mg of mAb M2A to 1 ml protein A-Sepharose 4B (Pharmacia, Baie d'Urfé, Quebec, Canada), as described previously (Schneider et al, 1982) . The column was washed extensively, first with lysis buffer, then with the same buffer containing 0.5% sodium deoxycholate and 0.5% SDS, and finally, with the same buffer containing 0.5% of n-octylglucoside (Boehringer Mannheim, Montreal, Quebec, Canada). The bound antigen was eluted with 50 mM diethylamine, pH 11.5, containing 0.5% sodium deoxycholate, neutralized, concentrated and analysed by SDS-PAGE in 8.5% slab gels under non-reducing conditions. The protein bands were visualized by silver staining using a commercial reagent (Bio-Rad, Mississauga, ON, Canada), and the proteins reacting with mAb M2A were identified by Western blotting.
Enzymatic digestion
Vibrio cholera neuraminidase, Pasteurella haemolytica O-sialoglycoprotease and Bacillus cereus phosphatidylinositol phospholipase C digestions were performed on whole cells and purified antigen preparations. HEY cells were harvested by incubation in PBS containing 20 mM EDTA and resuspended at a concentration of 1 × 10 7 per ml in PBS. Aliquots of 100 µl were treated with 5 units of neuraminidase (BDH, Mississauga, ON, Canada), 5 µl of O-sialoglycoprotease (Cederlane, Hornby, ON, Canada), or 5 µl of phosphatidylinositol phospholipase C (Boehringer Mannheim), for 30 min at 37°C. The cells were washed, incubated with mAb M2A, D1-26, or D2-40, followed by a fluorescein isothiocyanateconjugated F(ab´) 2 fragment of goat anti-mouse Ig antibody, and analysed by flow cytometry using a BD FACScan flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA).
For treatment of partially purified antigen preparations, 10 µl (0.15 µg) aliquots of the material eluted from the M2A-Sepharose column were mixed with 1 µl of 50 mM sodium acetate buffer, pH 5.4, and incubated with 0.1-2 units of neuraminidase, or 5 µl of O-sialoglycoprotease, for 15 min to 3 h at 37°C. The reactions were stopped by boiling, and the treated aliquots were analysed by Western blotting.
Analysis of 125 I-labelled surface proteins
HEY cell surface proteins were labelled enzymatically with 125 I using lactoperoxidase, as described previously (Sutherland et al, 1988) . Cell lysates were prepared as described above and immunoprecipitated with mAb M2A and protein A-Sepharose beads (Bailey et al, 1986) . The 125 I-labelled protein was released from the immunoprecipitate by boiling for 5 min in 100 µl of sample buffer, 0.1 M Tris, pH 6.8, containing 10% glycerol and 2% SDS (nonreduced protein), or of sample buffer containing 2% 2-mercaptoethanol (reduced protein), analysed by SDS-PAGE in 10% polyacrylamide slab gels, and visualized by autoradiography, as described previously (Sutherland et al, 1984) .
Peanut agglutinin (PNA) chromatography of desialylated immunoprecipitated protein was performed as described previously (Sutherland et al, 1988) . The bound protein fraction was analysed by SDS-PAGE and autoradiography.
For endoglycosidase digestion, the M2A antigen was eluted from the gel, recovered by precipitation in 10% trichloroacetic acid, divided into aliquots and digested with endoglycosidase H (Eli Lilly, Indianapolis, IN, USA), peptide:N-glycosidase F (Boehringer Mannheim), or sham-digested, as described previously (Sutherland et al, 1988) . The treated protein was recovered by precipitation in 10% trichloroacetic acid, and analysed by SDS-PAGE and autoradiography.
Immunoperoxidase staining
Sections of archival collections of TGCT were obtained through the Departments of Pathology of The Toronto Hospital, General Division, and The Princess Margaret Hospital (Toronto, ON, Canada). Immunoperoxidase staining of tissue sections was performed as previously described (Bailey et al, 1986) , with the following modifications. Following incubation with hybridoma supernatant or purified mAb (0.1-10 µg ml -1 ), the sections were incubated with biotinylated goat anti-mouse IgG antibody (Dako, Carpinteria, CA, USA) at a 1:400 dilution followed by a horseradish peroxidase-avidin conjugate (Zymed, San Francisco, CA, USA) at a 1:600 dilution. For colour development, the sections were incubated with 0.05% diaminobenzidine and 0.03% H 2 O 2 in PBS.
RESULTS
Production of mAb
Previously derived mAb M2A (IgG2a) was found to react with an oncofetal testicular antigen in frozen sections and tissues preserved in specialized fixatives, such as Stieve's, Bouin's and Cleland's reagents (Bailey et al, 1986; Giwercman et al, 1991) . In order to generate additional mAb for the biochemical characterization of M2A antigen and its immunohistochemical detection in archival specimens, we immunized mice with DG and screened hybridoma supernatants for reactivity with sections of formalinfixed, paraffin-embedded SE. The underlying rationale for this approach was twofold. First, it was expected to yield mAb directed to antigens (including M2A antigen) shared by SE and DG, and second, the direct screen with SE sections, as specified above, would ensure that the selected mAb reacted with conventionally preserved archival collections of tissues. In fact, two mAb, D1-26 (IgG2b) and D2-40 (IgG1), were successfully obtained using this approach. Of the two, D2-40 reacted strongly with sections of formalin-fixed, paraffin-embedded tissues, whereas D1-26 reacted only weakly and inconsistently. Therefore, D2-40 was used for all subsequent immunohistochemical staining of conventionally preserved archival material. Both D1-26 and D2-40 reacted strongly with tissues preserved in B5 fixative, a mercuric-type reagent used to preserve the immunoreactivity of membrane antigens. In contrast, mAb M2A did not react with tissues fixed in formalin and only weakly with those fixed in B5.
Distribution of M2A antigen in fetal and neoplastic testicular tissue mAb D1-26 and D2-40 stained testicular SE fixed in B5 or formalin, respectively, with strong accentuation of tumour cell membranes (Figure 1 B,C) , similar to that observed with M2A in frozen sections ( Figure 1A ). Paranuclear staining was also seen with mAb D2-40 ( Figure 1D) , indicative of the location of the antigen in the paranuclear Golgi network where glycoproteins are processed prior to their insertion into the membrane. D2-40 also stained sections of DG used for the original immunization of mice ( Figure 1E ), EC ( Figure 1F ), CIS ( Figure 1G ) and fetal testis ( Figure 1H ). There was no staining of uninvolved adult testis in the vicinity of germ cell neoplasia ( Figure 1G ). There was uniform membrane staining of tumour cells in SE, DG and CIS (Figure 1 C,E,G), whereas staining in EC ( Figure 1F ) was focal in distribution, concentrated at the lumenal surface of the membrane in the tumour cells which lined glands. D2-40 also stained primary extratesticular SE, including pineal (2/2) and mediastinal (2/2). This pattern of reactivity with testicular and extratesticular SE, DG, CIS and fetal, but not adult, testis is the same as that previously observed for mAb M2A in these tissues. In earlier studies on a limited number of cryopreserved TGCT, mAb M2A stained only CIS and SE, but not the other types of TGCT (Bailey et al, 1991) . Since mAb D2-40 reacted with formalin-fixed, paraffin-embedded material, it was possible to extend these studies by examining an archival collection of 69 TGCT for the distribution of M2A antigen. This collection included 41 pure TGCT (35 SE, 5 EC and 1 IT), and 28 mixed germ cell tumours (MGCT). The results of this survey are summarized in Table 1 .
When the results obtained with pure TGCT and the corresponding components of MGCT were combined, mAb D2-40 was found to stain 98% of SE, 69% of EC, 29% of IT and MT, and 25% of YS. There was no difference in staining between IT and MT.
The only SE specimen that did not stain was an anaplastic SE, a tumour type that has been previously noted to display an aberrant pattern of antigen expression (Rajpert-De Meyts et al, 1996) . There was 100% staining of CIS in association with both seminomatous and non-seminomatous TGCT. Whereas uniform membrane staining was observed in SE and CIS, the staining in EC, IT, MT and YS was focal in distribution, concentrated at the lumenal surface of the membrane in the tumour cells which lined glands. There was no staining of the uninvolved testicular tubules in the vicinity of tumour cells in any of the specimens.
Reactivity of mAb with human tumour cell lines
The reactivity of the mAb with human tumour cell lines was determined by Western blotting on cell lysates. A representative Western blot is shown in Figure 2 . In ovarian cancer HEY cell lysates, M2A and D2-40 reacted with an M r 40 000 antigen, and D1-26 reacted with a doublet form of the antigen. In bladder cancer MGH-U3 cells, M2A and D2-40, but not D1-26, reacted with a slightly higher molecular weight form of the antigen. Neither M2A, D2-40 nor D1-26 reacted with colon cancer Caco-2 cells. The reactivity of mAb M2A, D2-40 and D1-26 with a panel of human cancer cell lines, determined by Western blotting, is summarized in Table 2 .
All three mAb reacted with three ovarian epithelial carcinoma cell lines, HEY, Caov-3 and SK-OV-3, and the osteosarcoma cell line U-2 OS. Among germ cell tumour cell lines, D2-40, but not M2A or D1-26, reacted with the ovarian teratocarcinoma PA-1, the testicular teratocarcinomas Tera-1 and Tera-2, and the embryonal carcinoma 833. There was no reactivity with the testicular teratocarcinoma 577 and the embryonal carcinoma 1618. In addition, M2A and D2-40, but not D1-26, reacted with the bladder transitional cell carcinoma cell lines MGH-U3 and RT-4. There was no reactivity with any of the other cell lines derived from a wide spectrum of human cancers, including ovary, bladder, breast, prostate, melanoma, cervix, colon, pharynx, brain and bone marrow.
The binding affinities of M2A, D1-26 and D2-40 to HEY cells were found to be 2 × 10 9 M -1 , 2 × 10 8 M -1 , and 2 × 10 8 M -1 , respectively, on the basis of Scratchard plot and binding displacement analyses.
Antigen purification
Preliminary lectin affinity chromatography experiments indicated that the antigen recognized by the mAb bound to WGA, but not to concanavalin A or R. communis agglutinin. The antigen was purified from HEY cell lysates by sequential affinity chromatography and D1-26, but not D2-40, was also destroyed by treatment with neuraminidase ( Figure 4A , lane c), showing that a terminal sialic acid residue in the epitope was required for reactivity with M2A and D1-26. Sequential digestion of the purified antigen preparation with increasing amounts of neuraminidase demonstrated a slower migration of the antigen with progressive removal of negatively charged sialic acid residues ( Figure 4B ). This was seen using mAb D2-40, which reacted with the desialylated antigen, and M2A, which still reacted with the antigen after partial removal of the sialic acid residues. In contrast, the reactivity of D1-26 with the antigen was exquisitely sensitive to neuraminidase digestion, and was lost after removal of sialic acid under the mildest conditions used for digestion with the enzyme.
The above results were extended using HEY cell cultures by performing enzymatic digestions on whole cells and detection of the surface antigen by flow cytometry (Figure 5 ). Reactivity with all three mAb was sensitive to digestion with O-sialoglycoprotease, although reactivity with D1-26 was less sensitive to digestion with the enzyme than reactivity with M2A and D2-40 ( Figure 5 , thin solid line). On the other hand, reactivity with D1-26 was most sensitive to digestion with neuraminidase, reactivity with M2A was partially sensitive, and reactivity with D2-40 was resistant to digestion with the enzyme (Figure 5 , thick solid line), confirming the results obtained using Western blot analysis.
Reactivity of HEY cells with mAb M2A, as assessed by flow cytometry, was not affected by treatment with phosphatidylinositol phospholipase C, suggesting that the antigen was not anchored in the membrane through a glycophosphatidylinositol linkage (data not shown).
Analysis of 125 I-labelled surface proteins
HEY cell surface proteins were labelled with 125 I using lactoperoxidase, immunoprecipitated indirectly using mAb M2A and protein A-Sepharose, dissociated from the immune complex under reducing and non-reducing conditions, and analysed by SDS-PAGE. A single M r 40 000 band was visualized on the autoradiogram under both reducing and non-reducing conditions ( Figure 6A , lanes 1 and 2), corresponding to the monomeric form of the antigen demonstrated previously by Western blotting (Figures 2 and 3) .
Two approaches were used to further characterize the carbohydrate structure of the antigen. In the first approach, the 125 I-labelled protein was dissociated from the immunoprecipitate, digested with neuraminidase to remove sialic acid and incubated with PNASepharose beads. The protein bound to the lectin was dissociated from the beads and analysed by SDS-PAGE. A single protein band was visualized on the autoradiogram, migrating more slowly (M r 42 000) than the antigen immunoprecipitated without treatment with neuraminidase ( Figure 6A, lane 3) .
In the second approach, the 125 I-labelled protein was again immunoprecipitated, dissociated from the immunoprecipitate and subjected to SDS-PAGE as described above. The 125 I-labelled antigen was eluted from the polyacrylamide gel, incubated with buffer alone, endoglycosidase H, or peptide:N-glycosidase F, and re-analysed by SDS-PAGE ( Figure 6B, lanes 6-8) . The antigen was not cleaved by digestion with either of these enzymes.
DISCUSSION
mAb M2A was found to react with a membrane antigen present on fetal gonocytes, CIS and SE in testicular tissues preserved by freezing or immersion in specialized fixatives (Bailey et al, 1986 (Bailey et al, , 1991 Giwercman et al, 1988 Giwercman et al, , 1991 Jørgensen et al, 1995) . In order to extend these results on the distribution of M2A antigen and elucidate its biochemical structure, our experimental goal was to produce mAb with a similar specificity to M2A which also reacted with formalin-fixed, paraffin-embedded material.
Since M2A antigen was present on SE and its female counterpart, DG, we used an experimental strategy to immunize mice with DG, and to screen hybridomas, derived by fusion of splenocytes of immunized mice, for production of mAb reacting with sections of formalin-fixed, paraffin-embedded SE specimens. This strategy was successful and two mAb were produced, D1-26 and D2-40, which reacted with B5-and formalin-fixed, paraffin-embedded tissues (Figure 1 ) with a specificity for fetal gonocytes, CIS, testicular and extratesticular SE, and DG similar to that demonstrated previously for mAb M2A (Bailey et al, 1986 (Bailey et al, , 1991 Jørgensen et al, 1995) . The conclusive evidence that the three mAb reacted with the same antigen was provided by purifying the M r 40 000 antigen from HEY cell lysates (Figure 3) , and demonstrating that the three mAb reacted with the same purified antigen (Figure 4) . The success in selecting the hybridoma clones producing mAb D1-26 and D2-40 by screening on SE following immunization of mice with DG, a procedure completely different from that used to produce mAb M2A by immunization with HEY cells, suggests that the M2A antigen recognized by the three mAb may be an immunodominant antigen on SE and DG.
M2A antigen was expressed in several human cancer cell lines, including three ovarian epithelial carcinoma, one ovarian and two testicular teratocarcinoma, one embryonal carcinoma, one osteosarcoma and two bladder transitional carcinoma, but was absent in many other cell lines derived from a variety of human tumours (Table 2 ). At present, it is not known whether the expression of this antigen in a number of human cancer cell lines is indicative of a lineage-specific marker shared by the cell line and the tumour from which it was derived, or alternatively, whether the presence of the antigen represents an aberrant expression of the protein by the transformed cell line in vitro.
The presence of the antigen in the paranuclear Golgi apparatus suggested that it was a glycoprotein ( Figure 1D ). This suggestion was supported by variations in the molecular weight of the antigen (Figure 2 ) and in its recognition by the individual mAb (Table 2) in human cancer cell lines, likely reflecting differences in glycosylation. In confirmation of this suggestion, reactivity with the mAb was sensitive to digestion with O-sialoglycoprotease and neuraminidase on the basis of Western blotting and flow cytometric analyses (Figures 4 and 5) , indicating that the antigen was an O-linked sialoglycoprotein exposed on the cell surface. As expected, removal of the negatively charged sialic acid residues decreased the electrophoretic mobility of the antigen ( Figure 4B) . Furthermore, the reactivity of the three mAb with their respective complementary carbohydrate epitopes was differentially affected by treatment with neuraminidase, D1-26 reactivity being exquisitively sensitive to the removal of sialic acid, D2-40 reactivity completely resistant, and M2A reactivity intermediate between the other two (Figures 4 and 5) .
We took advantage of the surface localization of the antigen to label it with 125 I using lactoperoxidase. This allowed a more direct examination of its molecular structure in its usual membrane location. Following immunoprecipitation of the 125 I-labelled HEY cell surface proteins with mAb M2A and SDS-PAGE, a single protein band was visualized on the autoradiogram after dissociation of the immunoprecipitate under both reducing and nonreducing conditions ( Figure 6A ). This suggests that the antigen exists as a monomer and is not complexed with another membrane protein. The dimeric form, previously observed in the purified antigen preparation (Figure 3) , likely is formed by aggregation during the purification procedure. Alternatively, the dimeric form in the membrane may not be accessible to iodination with lactoperoxidase.
The 125 I-labelled antigen was found to be resistant to digestion with endoglycosidase H and peptide:N-glycosidase F, enzymes which cleave asparagine-bonded oligomannosyl cores of precursor N-linked glycoproteins and also complex-type N-linked glycans characteristic of the fully processed cell surface glycoproteins (Tarentino and Maley, 1974; Plummer et al, 1984; Sutherland et al, 1988) (Figure 6B ). These results confirmed that the antigen was an O-linked glycoprotein with no N-linked sugar groups. Absence of N-linked sugar residues was also consistent with the lack of binding of the antigen to concanavalin A, which binds specifically to N-linked glycans (Wu et al, 1988) , and our inability to radiolabel the antigen metabolically using the non-convertible D-[2-3 H]mannose precursor of N-linked sugars (unpublished observations).
In order to characterize further the carbohydrate structure of the antigen recognized by the mAb, we used affinity chromatography on PNA-Sepharose. PNA binds to the structure Gal β(1-3) GalNAc-0-Thr/Ser which is found only in O-linked glycoproteins (Wu et al, 1988) . When the 125 I-labelled M2A immunoprecipitate was digested with neuraminidase and fractionated on PNASepharose, the desialylated antigen was found to bind to the lectin. Following elution from the lectin, the desialylated antigen migrated more slowly in SDS-PAGE than the native antigen ( Figure 6A ), as shown previously by Western blotting ( Figure 4B ). Removal of sialic acid was essential for binding to PNASepharose, as the native antigen did not bind to the lectin (unpublished observations). Similarly, failure of the native antigen to bind to R. communis agglutinin confirmed the absence of exposed galactose or N-acetyl galactosamine residues, and binding to WGA was also consistent with terminal sialylation (Peters et al, 1979) . In addition, reactivity of the antigen with mAb M2A was destroyed by treatment with periodate, a reaction that oxidizes the terminal sialic acid residues of glycoproteins (unpublished results).
The results of enzyme digestion and lectin fractionation suggest that the antigen recognized by mAb M2A, D1-26 and D2-40 contains the simple mucin-type carbohydrate structure shown below. SA α(2-3) Gal β(1-3) GalNAc-0-Thr/Ser | α (2-6) SA where SA denotes sialic acid, Gal galactose and GalNAc N-acetyl galactosamine.
The above carbohydrate structure is common in mucin-type glycoproteins that are expressed widely on human normal cells and tumours (Sutherland et al, 1988; Corraway and Hull, 1989; Lesuffleur et al, 1994) . Therefore, the remarkable specificity of mAb M2A, D1-26 and D2-40 for fetal gonocytes, CIS and germ cell tumours is likely based on the recognition by these mAb of a mixed epitope whose structure is determined by the polypeptide core together with the O-linked carbohydrate chain.
Two models have been proposed for the progression of testicular CIS to invasive TGCT. In the independent progression model, CIS can progress directly to SE and EC. In the linear progression model, SE is an intermediate stage between CIS and EC. In both models, EC is believed to be the precursor of IT and MT, YS and CC. Our results do not distinguish between the two models, but demonstrate a reprogramming in the expression of M2A antigen during the transition of either CIS or SE to EC, and of EC to IT, MT, YS and CC. Specifically, although there was uniform cell membrane expression of M2A antigen in CIS and SE, there was either no expression in EC, or focal membrane expression ( Figure  1 , Table 1 ). Furthermore, while this focal pattern of expression was common to all non-seminomatous TGCT that expressed M2A antigen, complete absence of expression was seen more frequently in IT, MT, YS and CC than in EC (Table 1) . This is compatible with the notion that progressive loss of M2A antigen expression occurs when EC becomes transformed into the other non-seminomatous TGCT types.
M2A antigen belongs to the set of antigenic and molecular markers that are useful to follow the transformation of fetal gonocytes to CIS and the progression of CIS to invasive TGCT. At present, the elucidation of the carbohydrate epitope of M2A antigen does not allow us to make any functional correlations between the structure of the epitope and the above transitions. However, such a correlation may be possible when additional information about critical glycosylation reactions and mechanisms of receptor activation influencing these becomes available. In addition, the availability of mAb D2-40 which reacts with M2A antigen in conventionally preserved surgical specimens, opens up the way to examining archival collections of tissues for the expression of this antigen and further correlating this expression with milestones in the origin and progression of germ cell neoplasia.
